Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Gender identity disorders and multiple sclerosis risk: A national record-linkage study.
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Daclizumab discontinue letter for the US market
GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease.
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
Alemtuzumab
Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results.
Glatiramer acetate ameliorates experimental autoimmune neuritis.
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons.
Antigen-specific tolerance by autologous myelin Peptide-coupled cells: a phase 1 trial in multiple sclerosis.
Gait Mechanics are Different between Healthy Controls and Patients with Multiple Sclerosis.
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.
Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
Glatiramer acetate in the treatment of multiple sclerosis
Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis.
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators.
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US (MANAGE)
Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.
B cells and multiple sclerosis.
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis.

Pages